Next Article in Journal
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
Next Article in Special Issue
Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
Previous Article in Journal / Special Issue
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Article Menu

Export Article

Open AccessReview
Vaccines 2015, 3(3), 686-702;

Gas Vesicle Nanoparticles for Antigen Display

Department of Microbiology and Immunology, Institute of Marine and Environmental Technology, University of Maryland, Baltimore, MD 21202, USA
Author to whom correspondence should be addressed.
Academic Editor: Darrell J. Irvine
Received: 26 June 2015 / Revised: 17 August 2015 / Accepted: 31 August 2015 / Published: 7 September 2015
(This article belongs to the Special Issue Nanoparticle-Based Vaccines)
Full-Text   |   PDF [432 KB, uploaded 7 September 2015]   |  


Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable, and self-adjuvanting. A large gene cluster encoding more than a dozen proteins has been implicated in their biogenesis. One protein, GvpC, found on the exterior surface of the nanoparticles, can accommodate insertions near the C-terminal region and results in GVNPs displaying the inserted sequences on the surface of the nanoparticles. Here, we review the current state of knowledge on GVNP structure and biogenesis as well as available studies on immunogenicity of pathogenic viral, bacterial, and eukaryotic proteins and peptides displayed on the nanoparticles. Recent improvements in genetic tools for bioengineering of GVNPs are discussed, along with future opportunities and challenges for development of vaccines and other applications. View Full-Text
Keywords: protein nanoparticle; adjuvant; carrier; SIV; Chlamydia; Salmonella; typhoid; Plasmodium; malaria; luciferase protein nanoparticle; adjuvant; carrier; SIV; Chlamydia; Salmonella; typhoid; Plasmodium; malaria; luciferase

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

DasSarma, S.; DasSarma, P. Gas Vesicle Nanoparticles for Antigen Display. Vaccines 2015, 3, 686-702.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top